
Astrazeneca scrapped £450m vaccine plant after government missed funding deadline
The FTSE 100 pharmaceutical company’s decision to withdraw its investment in the Speke, Liverpool site in January sparked political controversy, as the government seeks to attract private sector funding to revitalise Britain’s sluggish economy. Speaking to …